Goldman Sachs Group »

Tvardi Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $143k 33k 4.30
2025-09-30 $936k 24k 38.97

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Spdr S&p 500 Etf Tr CMN (SPY)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Eli Lilly & Co CMN (LLY)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
American Financial Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
FMR
Duncan Williams Asset Management
Squarepoint Ops
Northern Trust
Jane Street
Farallon Capital Management
UBS Group
Goldman Sachs Group

View all funds holding Tvardi Therapeutics